Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures

References

• Hill QA, Stamps R, Massey E, et al. British society for haematology guidelines. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017;177(2): 208–220.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124(19): 2930–2936.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Zaninoni A, Fattizzo B, et al. Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am J Hematol. 2018;93(9): E243–E246.
   PubMed Web of Science ®Google Scholar
• Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother. 2015;42(5):287–293.
   PubMed Web of Science ®Google Scholar
• Berentsen S. How I manage patients with cold agglutinin disease. Br J Haematol. 2018;181(3):320–330.
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Zaninoni A, Gianelli U, et al. Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia. Am J Hematol. 2018;93(4):E88–E91.
   PubMed Web of Science ®Google Scholar
• Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2019;100648. DOI: 10.1016/j.blre.2019.100648.
   PubMed Web of Science ®Google Scholar
• Brodsky RA. Warm Autoimmune Hemolytic Anemia. N Engl J Med. 2019;381(7):647–654.
   PubMed Web of Science ®Google Scholar
• Hill QA, Hill A, Berentsen S. Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. Blood Adv. 2019;3(12):1897–1906.
   PubMed Web of Science ®Google Scholar
• Abdel-Khalik A, Paton L, White AG, et al. Human leucocyte antigens A, B, C, and DRW in idiopathic “warm” autoimmune haemolytic anaemia. Br Med J. 1980;280(6216):760–761.
   PubMedGoogle Scholar
• Wang-Rodriguez J, Rearden A. Reduced frequency of HLA-DQ6 in individuals with a positive direct antiglobulin test. Transfusion. 1996;36(11–12):979–984.
   PubMed Web of Science ®Google Scholar
• Silberstein LE, Jefferies LC, Goldman J, et al. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood. 1991;78(9):2372–2386.
   PubMed Web of Science ®Google Scholar
• Potter KN, Hobby P, Klijn S, et al. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol. 2002;169(7):3777–3782.
   PubMed Web of Science ®Google Scholar
• Jefferies LC, Carchidi CM, Silberstein LE. Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment. J Clin Invest. 1993;92(6):2821–2833.
   PubMed Web of Science ®Google Scholar
• Malecka A, Trøen G, Tierens A, et al. Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity. Haematologica. 2016;101(9):e361–364.
   PubMed Web of Science ®Google Scholar
• Smirnova SJ, Sidorova JV, Tsvetaeva NV, et al. Expansion of CD8+ cells in autoimmune hemolytic anemia. Autoimmunity. 2016;49(3):147–154.
   PubMed Web of Science ®Google Scholar
• Pavkovic M, Georgievski B, Cevreska L, et al. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders. Am J Hematol. 2003;72(2):14714–14719.
   Web of Science ®Google Scholar
• D’Abronzo LS, Barros MM, Bordin JO, et al. Analysis of polymorphisms of TNF-a, LT-a, IL-10, IL-12 and CTLA-4 in patients with warm autoimmune haemolytic anaemia. Int J Lab Hematol. 2012;34(4):356–361.
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Aladjidi N, Fernandes H, et al. members of the French reference center for pediatric autoimmune cytopenia (CEREVANCE). Pediatric evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134(1): 9–21.
   PubMed Web of Science ®Google Scholar
• Klemann C, Esquivel M, Magerus-Chatinet A, et al. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome. Haematologica. 2017;102(2):e52–e56.
   PubMed Web of Science ®Google Scholar
• Rao VK, Webster S, Dalm VASH, et al. Effective “activated PI3Kd syndrome”-targeted therapy with the PI3Kd inhibitor leniolisib. Blood. 2017;130(21):2307–2316.
   PubMed Web of Science ®Google Scholar
• Schwab C, Gabrysch A, Olbrich P, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932–1946.
   PubMed Web of Science ®Google Scholar
• Del Bel KL, Ragotte RJ, Saferali A, et al. JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome. J Allergy Clin Immunol. 2017;139(6):2016–2020.e5.
   PubMed Web of Science ®Google Scholar
• Malecka A, Trøen G, Tierens A, et al. Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease. Br J Haematol. 2018;183(5): 838–842.
   PubMed Web of Science ®Google Scholar
• Margot H, Boursier G, Duflos C, et al. Immunopathological manifestations in kabuki syndrome: a registry study of 177 individuals. Genet Med. 2020;22(1):181–188.
   PubMed Web of Science ®Google Scholar
• Almécija AC, Pérez V, Baro M, et al. Atypical autoimmune hematologic disorders in a patient with kabuki syndrome. J Pediatr Hematol Oncol. 2019;41(2):e114–e115.
   PubMed Web of Science ®Google Scholar
• Xu LH, Fang JP, Weng WJ, et al. Autoimmune hemolytic anemia in patients with ß-thalassemia major. Pediatr Hematol Oncol. 2012;29(3):235–240.
   PubMed Web of Science ®Google Scholar
• Khaled MB, Ouederni M, Sahli N, et al. Predictors of autoimmune hemolytic anemia in beta-thalassemia patients with underlying red blood cells autoantibodies. Blood Cells Mol Dis. 2019;79:102342.
   PubMed Web of Science ®Google Scholar
• Inaba H, Geiger TL, Lasater OE, et al. A case of hemoglobin SC disease with cold agglutinin-induced hemolysis. Am J Hematol. 2005;78(1):37–40.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Ishida H, Yoshihara T, et al. Complications of Evans’ syndrome in an infant with hereditary spherocytosis: a case report. J Hematol Oncol. 2009;2(1):40.
   PubMedGoogle Scholar
• Zaninoni A, Vercellati C, Imperiali FG, et al. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis. Transfusion. 2015;55(12):2930–2938.
   PubMed Web of Science ®Google Scholar
• Feuille EJ, Anooshiravani N, Sullivan KE, et al. Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry. J Clin Immunol. 2018;38(1):28–34. .
   PubMed Web of Science ®Google Scholar
• Odineal DD, Gershwin ME. The epidemiology and clinical manifestations of autoimmunity in selective IgA deficiency. Clin Rev Allergy Immunol. 2019;58(1):107–133.
   Web of Science ®Google Scholar
• Oliveira JB. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr. 2013;25(6):722–729.
   PubMed Web of Science ®Google Scholar
• Baris HE, Kiykim A, Nain E, et al. The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency. Turk Pediatri Ars. 2016;51(4):186–192.
   PubMedGoogle Scholar
• Gormezano NW, Kern D, Pereira OL, et al. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients. Lupus. 2017;26(4):426–430.
   PubMed Web of Science ®Google Scholar
• Katsumata K. A case of systemic sclerosis complicated by autoimmune hemolytic anemia. Mod Rheumatol. 2006;16(3):191–195.
   PubMedGoogle Scholar
• Jordana R, Tolosa C, Selva A, et al. Autoimmune hemolytic anemia and CREST syndrome. Med Clin (Barc). 1990;94(19):740–741.
   PubMed Web of Science ®Google Scholar
• Rosenthal DS, Sack B. Autoimmune hemolytic anemia in scleroderma. JAMA. 1971;216(12):2011–2012.
   PubMed Web of Science ®Google Scholar
• Oh HJ, Yun MJ, Lee ST, et al. Evans syndrome following long-standing hashimoto’s thyroiditis and successful treatment with rituximab. Korean J Hematol. 2011;46(4):279–282.
   PubMedGoogle Scholar
• Moore JA, Gliga L, Nagalla S. Thyroid storm and warm autoimmune hemolytic anemia. Transfus Apher Sci. 2017;56(4):606–608.
   PubMed Web of Science ®Google Scholar
• Naji P, Kumar G, Dewani S, et al. Graves’ disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature. Case Rep Med. 2013;2013:194542.
   PubMedGoogle Scholar
• Hegazi MO, Ahmed S. Atypical clinical manifestations of graves’ disease: an analysis in depth. J Thyroid Res. 2012;2012:768019.
   PubMedGoogle Scholar
• Qiao L, Chen J, Leng XM, et al. Agranulocytosis and mixed-type autoimmune hemolytic anemia in primary sjögren’s syndrome: a case report and review of the literature. Int J Rheum Dis. 2016;19(12):1351–1353.
   PubMed Web of Science ®Google Scholar
• Wen W, Liu Y, Zhao C, et al. Clinical and serologic features of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study. Clin Rheumatol. 2015;34(11):1877–1884.
   PubMed Web of Science ®Google Scholar
• Uzzan M, Galicier L, Gornet JM, et al. Autoimmune cytopenias associated with inflammatory bowel diseases: insights from a multicenter retrospective cohort. Dig Liver Dis. 2017;49(4):397–404.
   PubMedGoogle Scholar
• Efe C, Wahlin S, Ozaslan E, et al. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol. 2012;24(5):531–534.
   PubMed Web of Science ®Google Scholar
• Gentile M, Verta M, Vigna E, et al. Autoimmune hemolytic anemia concomitant with sequential autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Hashimoto’s thyroiditis: a new entity of autoimmune polyendocrine syndrome. J Endocrinol Invest. 2009;32(3):287–288.
   PubMed Web of Science ®Google Scholar
• El Khoury C, Farhat H. Severe acute anemia attributable to concomitant occurrence of AIHA with PRCA induced by parvovirus B19 infection. Blood. 2018;131(12):1388.
   PubMed Web of Science ®Google Scholar
• Giovannetti G, Pauselli S, Barrella G, et al. Severe warm autoimmune haemolytic anaemia due to anti-Jk(a) autoantibody associated with Parvovirus B19 infection in a child. Blood Transfus. 2013;11(4):634–635.
   PubMed Web of Science ®Google Scholar
• Khawaja S, Abdul Muqtadir K, Taj Y. Warm autoimmune haemolytic anaemia and autoimmune hepatitis in an asymptomatic carrier of hepatitis B virus. J Pak Med Assoc. 2011;61(5):512–515.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, García-Carrasco M, López-Medrano F, et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore). 2003;82(2):87–96.
   PubMed Web of Science ®Google Scholar
• Chiao EY, Engels EA, Kramer JR, et al. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med. 2009;169(4):357–363.
   PubMedGoogle Scholar
• Wilkinson LS, Petz LD, Garratty G. Reappraisal of the role of anti-i in haemolytic anaemia in infectious mononucleosis. Br J Haematol. 1973;25(6):715–722.
   PubMed Web of Science ®Google Scholar
• Lebrun D, Hentzien M, Cuzin L, et al. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort. AIDS. 2017;31(15):2159–2166.
   PubMed Web of Science ®Google Scholar
• Atta M, Brannigan ET, Bain BJ. Cold autoimmune hemolytic anemia secondary to atypical pneumonia. Am J Hematol. 2017;92(1):109.
   PubMed Web of Science ®Google Scholar
• Stein B, DeCredico N, Hillman L. Evaluation of the direct antiglobulin test (DAT) in the setting of mycoplasma pneumoniae infection. JAMA. 2018;319(13):1377–1378.
   PubMed Web of Science ®Google Scholar
• Morell S, Lambert M, Queyrel V, et al. Tubercular adenitis and Evans’ syndrome. Lupus. 2006;15(2):114–115.
   PubMed Web of Science ®Google Scholar
• Wu B, Rong R. Cold agglutinin syndrome with severe haemolytic anaemia in a patient diagnosed of disseminated tuberculosis and concomitant Mycoplasma pneumoniae infection. Transfus Med. 2012;22(2):151–152.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Goldacre R, Skingsley A, et al. Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med. 2013;11(1):97.
   PubMedGoogle Scholar
• Eskazan AE, Dal MS, Kaya S, et al. Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis. Intern Med. 2014;53(11):1153–1158.
   PubMed Web of Science ®Google Scholar
• Leibrandt R, Angelino K, Vizel-Schwartz M, et al. Paroxysmal cold hemoglobinuria in an adult with respiratory syncytial virus. Case Rep Hematol. 2018;2018:7586719.
   PubMed Web of Science ®Google Scholar
• Zeller MP, Arnold DM, Al Habsi K, et al. Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients. Transfusion. 2017;57(1):137–143.
   PubMed Web of Science ®Google Scholar
• Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012;11(4):635–642.
   PubMed Web of Science ®Google Scholar
• Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005;42(3):137–144.
   PubMed Web of Science ®Google Scholar
• Weiss RB, Freiman J, Kweder SL, et al. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. J Clin Oncol. 1998;16(5):1885–1889.
   PubMed Web of Science ®Google Scholar
• Molica S, Polliack A. Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy. Leuk Res. 2016;50:31–36.
   PubMed Web of Science ®Google Scholar
• Fischer K, Bahlo J, Fink AM, et al. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. Blood. 2016;127(2):208–215.
   PubMed Web of Science ®Google Scholar
• Frustaci AM, Montillo M, Picardi P, et al. Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future? Expert Rev Hematol. 2016;9(7):679–693.
   PubMed Web of Science ®Google Scholar
• Vitale C, Burger JA. Chronic lymphocytic leukemia therapy: new targeted therapies on the way. Expert Opin Pharmacother. 2016;17(8):1077–1089.
   PubMed Web of Science ®Google Scholar
• Rogers KA, Woyach JA. Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Semin Oncol. 2016;43(2):300–310.
   PubMed Web of Science ®Google Scholar
• Lampson BL, Kasar SN, Matos TR, et al. Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. Blood. 2016;128(2):195–203.
   PubMed Web of Science ®Google Scholar
• Furman RR, Sharman JP, Coutre SE, et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med. 2014;370(11):997–1007.
   PubMed Web of Science ®Google Scholar
• Hampel PJ, Larson MC, Kabat B, et al. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. Br J Haematol. 2018;183(3):421–427.
   PubMed Web of Science ®Google Scholar
• Klein NP, Ray P, Carpenter D, et al. Rates of autoimmune diseases in kaiser permanente for use in vaccine adverse event safety studies. Vaccine. 2010;28(4):1062–1068.
   PubMed Web of Science ®Google Scholar
• Payne D, Muss HB, Homesley HD, et al. Autoimmune hemolytic anemia and ovarian dermoid cysts: case report and review of the literature. Cancer. 1981;48(3):721–724.
   PubMed Web of Science ®Google Scholar
• Canale D, Feldman R, Rosen M, et al. Autoimmune hemolytic anemia associated with seminoma. Urology. 1975;5(3):411–414.
   Google Scholar
• Bernard C, Frih H, Pasquet F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15(1):82–92.
   PubMed Web of Science ®Google Scholar
• Ugoeke N, Onweni C, Treece J, et al. inflammatory breast cancer and warm antibody autoimmune hemolytic anemia: a rare paraneoplastic syndrome. J Investig Med High Impact Case Rep. 2017;5(4):2324709617740905.
   Web of Science ®Google Scholar
• Nenova IS, Valcheva MY, Beleva EA, et al. Autoimmune phenomena in patients with solid tumors. Folia Med (Plovdiv). 2016;58(3):195–199.
   PubMedGoogle Scholar
• Dearden C. Disease-specific complications of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2008;2008(1):450–456.
   Google Scholar
• Visco C, Barcellini W, Maura F, et al. Autoimmune cytopenias in chronic lymphocytic leukemia. Am J Hematol. 2014;89(11): 1055–1062.
   PubMed Web of Science ®Google Scholar
• Crickx E, Poullot E, Moulis G, et al. Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma. Eur J Haematol. 2019;103(1):35–42.
   PubMed Web of Science ®Google Scholar
• Dasanu CA, Bockorny B, Grabska J, et al. Prevalence and pattern of autoimmune conditions in patients with marginal zone lymphoma: a single institution experience. Conn Med. 2015;79(4):197–200.
   PubMedGoogle Scholar
• Randen U, Trøen G, Tierens A, et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 2014;99(3):497–504.
   PubMed Web of Science ®Google Scholar
• Hauswirth AW, Skrabs C, Schützinger C, et al. Autoimmune hemolytic anemias, Evans’ syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48(6):1139–1149.
   PubMed Web of Science ®Google Scholar
• Lechner K, Chen YA. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma. Leuk Lymphoma. 2010;51(3):469–474.
   PubMed Web of Science ®Google Scholar
• Maura F, Visco C, Falisi E, et al. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia. Am J Hematol. 2013;88(1):32–36.
   PubMed Web of Science ®Google Scholar
• Maura F, Cutrona G, Fabris S, et al. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS One. 2011;6(8):e24313.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood. 2007;109(1):259–270.
   PubMed Web of Science ®Google Scholar
• Carli G, Visco C, Falisi E, et al. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome. Ann Hematol. 2016;95(6):863–870.
   PubMed Web of Science ®Google Scholar
• Ferrer G, Navarro A, Hodgson K, et al. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia. Leuk Lymphoma. 2013;54(9):2016–2022.
   PubMed Web of Science ®Google Scholar
• Dearden C, Wade R, Else M, et al. UK National Cancer Research Institute (NCRI); Haematological Oncology Clinical Studies Group; NCRI CLL Working Group. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood. 2008;111(4):1820–1826.
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Hewitt S, Booker DJ. Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes. J Clin Pathol. 1989;42(10):1088–1091.
   PubMed Web of Science ®Google Scholar
• Zaninoni A, Imperiali FG, Cattaneo A, et al. Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes. Transfusion. 2016;56(8):2037–2041.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Iurlo A, Radice T, et al. Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns. Leuk Res. 2013;37(11):1509–1515.
   PubMed Web of Science ®Google Scholar
• Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, et al. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol. 2005;78(4):302–305.
   PubMed Web of Science ®Google Scholar
• Tajima K, Yamamoto H, Suzuki I, et al. Autoimmune hemolytic anemia with warm-reactive immunoglobulin M antibody in multicentric castleman disease. Ann Hematol. 2013;92(6):849–851.
   PubMed Web of Science ®Google Scholar
• Li M, Goldfinger D, Yuan S. Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature. Transfusion. 2012;52(1):48–54.
   PubMed Web of Science ®Google Scholar
• Elimelakh M, Dayton V, Park KS, et al. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients. Haematologica. 2007;92(8):1029–1036.
   PubMed Web of Science ®Google Scholar
• Skeate R, Singh C, Cooley S, et al. Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products. Transfusion. 2013;53(2):419–423.
   PubMed Web of Science ®Google Scholar
• González-Vicent M, Sanz J, Fuster JL, et al. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfus Med Rev. 2018;pii: S0887-7963(17)30164–5.
   PubMed Web of Science ®Google Scholar
• Kruizinga MD, MJD VT, Bekker V, et al. Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients. Biol Blood Marrow Transplant. 2018;24(4):772–778.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B, Zaninoni A. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. J Blood Med. 2019;10:265–278.
   PubMed Web of Science ®Google Scholar
• Okawa S, Kayatani H, Fujiwara K, et al. Pembrolizumab-induced autoimmune hemolytic anemia and hemophagocytic lymphohistiocytosis in non-small cell lung cancer. Intern Med. 2019;58(5):699–702.
   PubMed Web of Science ®Google Scholar
• Algaze SD, Park W, Harrington TJ, et al. Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin. BMJ Case Rep. 2018;2018:pii: bcr-2017-221801.
   PubMedGoogle Scholar
• Tanios GE, Doley PB, Munker R. Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the food and drug administration database and review. Eur J Haematol. 2019;102(2):157–162.
   PubMed Web of Science ®Google Scholar
• Leaf RK, Ferreri C, Rangachari D, et al. Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors. Am J Hematol. 2019;94(5): 563–574.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B, Cortelezzi A. Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly. Eur J Intern Med. 2018;58:77–83.
   PubMed Web of Science ®Google Scholar
• Rattarittamrong E, Eiamprapai P, Tantiworawit A, et al. Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia. Hematology. 2016;21(6):368–374.
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Zaninoni A, Nesa F, et al. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias. Am J Hematol. 2015;90(8):E149–151.
   PubMed Web of Science ®Google Scholar
• Lafarge A, Bertinchamp R, Pichereau C, et al. Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann Hematol. 2019;98(3):589–594.
   PubMed Web of Science ®Google Scholar
• Audia S, Bach B, Samson M, et al. Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS One. 2018;13(11):e0207218.
   PubMed Web of Science ®Google Scholar
• Allgood JW, Jr CH. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med. 1967;43(2):254–273.
   PubMed Web of Science ®Google Scholar
• Barcellini W. The clinical dilemma and management of red cell autoantibodies. Expert Rev Hematol. 2016;9(4):325–327.
   PubMed Web of Science ®Google Scholar
• Roumier M, Loustau V, Guillaud C, et al. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients. Am J Hematol. 2014;89(9):E150–155.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers. 2015;2015:635670.
   PubMed Web of Science ®Google Scholar
• Barcellini W. Immune hemolysis: diagnosis and treatment recommendations. Semin Hematol. 2015;52(4):304–312.
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Michel M, Languille L, et al. Predictors of response to erythropoietin in autoimmune hemolytic anemia. Blood. 2019;134:3516.
   Web of Science ®Google Scholar